Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)
China · Delayed Price · Currency is CNY 26.39
+0.33 (1.27%)
At close: Jan 23, 2026
SHE:300813 Revenue
Zhejiang Tailin BioEngineering Co.,Ltd had revenue of 67.36M CNY in the quarter ending September 30, 2025, a decrease of -21.84%. This brings the company's revenue in the last twelve months to 319.72M, up 3.40% year-over-year. In the year 2024, Zhejiang Tailin BioEngineering Co.,Ltd had annual revenue of 349.00M with 29.33% growth.
Revenue (ttm)
319.72M
Revenue Growth
+3.40%
P/S Ratio
9.90
Revenue / Employee
401.15K
Employees
797
Market Cap
3.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 349.00M | 79.14M | 29.33% |
| Dec 31, 2023 | 269.86M | -104.02M | -27.82% |
| Jan 1, 2023 | 373.88M | 90.63M | 32.00% |
| Jan 1, 2022 | 283.25M | 83.01M | 41.46% |
| Dec 31, 2020 | 200.24M | 19.31M | 10.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.60B |
| Guangdong Transtek Medical Electronics | 984.77M |
| Dirui Industrial | 511.11M |
| Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. | 480.25M |
| Jiangsu Canopus Wisdom Medical Technology | 403.18M |
| Shanghai General Healthy Information and Technology | 393.61M |
| Tellgen | 373.48M |
| Kontour (Xi'an) Medical Technology | 332.92M |